Status:

COMPLETED

Vitamin D for Improving Metabolic Control and Depressive Symptoms

Lead Sponsor:

Loyola University

Conditions:

Depressive Symptoms

Diabetes

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

This study will examine whether weekly vitamin D supplementation in women with significant depressive symptoms and diabetes will exhibit improved mood and metabolic control. If supplementation with Vi...

Eligibility Criteria

Inclusion

  • Women aged 18 and older
  • medically stable type 2 diabetes with HBA1c \<9%.
  • significantly elevated depressive symptoms as measured by a score greater than or equal to 14 using the Center for Epidemiologic Studies Depression Tool (CES-D.

Exclusion

  • vitamin D levels of 32 ng/dl or greater
  • malabsorption problems (e.g., crohn's disease, celiac sprue)
  • hypercalcemia-level greater than 10.5 mg/dl
  • Severe complications of diabetes (amputation, blindness, or renal problems) 5) Women with low thyroid function
  • 6\) active suicidal ideation, a history of bipolar depression, psychotic disorders, and current alcohol or substance disorders. Active treatment for depression (e.g., antidepressant therapy) will not be exclusion criteria 7) Any serious chronic illness that may impact on their health-related quality of life and treatment effect 8) Women who are pregnant 9) Women who have had bariatric surgery.

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2012

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01185574

Start Date

October 1 2009

End Date

May 1 2012

Last Update

July 11 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Loyola University Medical Center

Maywood, Illinois, United States, 60153